Funds · EPRX

Who owns EPRX?

Institutional ownership of Eupraxia Pharmaceuticals Inc. from Form 13F, Q2 2026

68 institutional managers reported holding Eupraxia Pharmaceuticals Inc. (EPRX) in Form 13F filings for Q2 2026, with 24,811,199 shares worth $164M. The largest reported holder was Beutel, Goodman & Co Ltd. Managers that filed both quarters added a net 1,387,273 shares (+6.3%). 16 opened new positions and 5 sold out.

Funds holding
68
Value held
$164M
New / sold out
16 / 5
Net shares, same filers
+6.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of EPRX

FundValueShare of 13F holdingsSharesMove
Beutel, Goodman & Co Ltd.$23.8M14.6%3,627,864Trimmed
Affinity Asset Advisors, LLC$10.9M6.7%1,650,000Added
Balyasny Asset Management L.P.$8.9M5.4%1,350,015Unchanged
Vivo Capital, LLC$8.9M5.4%1,350,000Unchanged
Scotia Capital Inc.$8.8M5.4%1,343,726Added
PFM Health Sciences, LP$8.0M4.9%1,210,661Added
Great Point Partners LLC$7.9M4.8%1,200,000Unchanged
Jupiter Topco LLC$6.9M4.2%1,046,000First report
Rubric Capital Management LP$5.7M3.5%867,424Added
Ikarian Capital, LLC$5.4M3.3%809,741Trimmed
Woodline Partners LP$4.9M3.0%746,864Added
Point72 Asset Management, L.P.$4.8M2.9%730,284Trimmed
Ameriprise Financial Inc$4.7M2.9%711,024Added
Redmile Group, LLC$4.0M2.5%611,400Trimmed
Seven Fleet Capital Management LP$4.0M2.5%610,785Added
UBS Group AG$3.4M2.1%519,211Trimmed
Citadel Advisors LLC$3.3M2.0%502,011Added
Millennium Management LLC$2.9M1.8%441,586New
Alyeska Investment Group, L.P.$2.5M1.5%375,000Unchanged
Picton Mahoney Asset Management$2.4M1.5%360,878New
Velan Capital Investment Management LP$2.3M1.4%352,000Unchanged
Jane Street Group, LLC$2.2M1.3%329,053Added
Aisling Capital Management LP$2.1M1.3%325,000Unchanged
SummitTX Capital, L.P.$2.1M1.3%318,784Trimmed
Royal Bank of Canada$2.1M1.3%311,435Added

Share of 13F holdings is each fund's shares as a share of the 24,811,199 EPRX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $27.6M and sold $19.2M; 21 added and 17 trimmed.

Schedule 13D and 13G filings on EPRX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about EPRX ownership

Who owns EPRX stock?
68 institutional investment managers reported EPRX positions in their Form 13F filings for Q2 2026, holding 24,811,199 shares worth $164M in total. Beutel, Goodman & Co Ltd. reported the largest position.
Are funds buying or selling EPRX?
In Q2 2026, 16 managers opened new EPRX positions, 21 added, 17 trimmed and 5 sold out. Managers that filed in both quarters added a net 1,387,273 shares.
How current is this EPRX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to EPRX by CUSIP. Options are left out. EPRX news and filings · EPRX insider trades · Top funds